亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

上海畢得醫(yī)藥科技有限公司  

主要生產(chǎn)環(huán)化合藥物包括吲哚,咪唑,吡唑,噠嗪,吡啶,嘧啶,哌嗪,哌啶,哌咯,噻唑,三唑類和其它醫(yī)藥中間體。

搜索
新聞中心
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:馬
  • 電話:86-21-61629020
  • 郵件:marketing_cn@bidepharmatech.com
  • 傳真:86-21-61629029
  • QQ:2959064341
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
  供應(yīng)產(chǎn)品
2-Fluoro-3-nitrobenzoic acid 面議0詢價(jià)
C6H2BrF2NO2 面議0詢價(jià)
C9H10N2O5S 面議0詢價(jià)
C9H8BrNO 面議0詢價(jià)
C8H14MgO10 面議0詢價(jià)
2-Bromo-6-fluorobenzaldehyde 面議0詢價(jià)
4-CHLORO-2-METHYLPYRIMIDINE 面議0詢價(jià)
4-Chloro-3-cyanopyridine 面議0詢價(jià)
C7H4BrIN2 面議0詢價(jià)
C8H9NO2 面議0詢價(jià)
C6H5ClFN 面議0詢價(jià)
C34H21Br 面議0詢價(jià)
C8H4BrF3O2 面議0詢價(jià)
C6H2ClF3N2O2 面議0詢價(jià)
C3H5N3O 面議0詢價(jià)
C8H17NO3 面議0詢價(jià)
©2025 上海畢得醫(yī)藥科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7529  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |